Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cyanotech (CYAN) Competitors

Cyanotech logo

CYAN vs. HAPP, SMFL, VYNE, KPRX, HCWB, ADXN, ENTO, CELZ, ALBT, and EVAX

Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Smart for Life (SMFL), VYNE Therapeutics (VYNE), Kiora Pharmaceuticals (KPRX), HCW Biologics (HCWB), Addex Therapeutics (ADXN), Entero Therapeutics (ENTO), Creative Medical Technology (CELZ), Avalon GloboCare (ALBT), and Evaxion A/S (EVAX).

Cyanotech vs. Its Competitors

Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medicinals & botanicals industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Cyanotech-19.50% -44.71% -19.12%
Happiness Development Group N/A N/A N/A

In the previous week, Happiness Development Group had 1 more articles in the media than Cyanotech. MarketBeat recorded 1 mentions for Happiness Development Group and 0 mentions for Cyanotech. Happiness Development Group's average media sentiment score of 0.75 beat Cyanotech's score of 0.00 indicating that Happiness Development Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cyanotech Neutral
Happiness Development Group Positive

Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyanotech$23.07M0.09-$5.27M-$0.66-0.44
Happiness Development Group$95.59M0.04-$49.19M$0.481.14

Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500.

24.4% of Cyanotech shares are owned by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are owned by institutional investors. 29.1% of Cyanotech shares are owned by company insiders. Comparatively, 15.6% of Happiness Development Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Happiness Development Group beats Cyanotech on 9 of the 13 factors compared between the two stocks.

Get Cyanotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYAN vs. The Competition

MetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$2.08M$3.88B$6.15B$10.57B
Dividend YieldN/AN/A5.72%4.81%
P/E Ratio-0.4410.0364.3622.95
Price / Sales0.0978.10610.57131.84
Price / CashN/A7.2437.1060.81
Price / Book0.221.4312.236.52
Net Income-$5.27M$19.57M$3.33B$276.93M

Cyanotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYAN
Cyanotech
0.5999 of 5 stars
$0.29
flat
N/A-58.6%$2.08M$23.07M-0.4495
HAPP
Happiness Development Group
N/A$1.03
-9.6%
N/A-15.7%$7.16M$95.59M2.15215High Trading Volume
SMFL
Smart for Life
N/A$0.00
flat
N/A-87.7%$19K$11.11M0.00110Gap Down
VYNE
VYNE Therapeutics
2.0446 of 5 stars
$0.39
+5.9%
$6.25
+1,502.6%
-82.7%$9.38M$500K-0.4330
KPRX
Kiora Pharmaceuticals
3.1313 of 5 stars
$2.74
+0.7%
$10.00
+265.0%
-18.6%$9.34MN/A-0.9410News Coverage
Positive News
Short Interest ↓
HCWB
HCW Biologics
2.2022 of 5 stars
$4.50
+6.6%
$35.00
+677.8%
-82.2%$9.08M$832.84K-0.3240News Coverage
Short Interest ↓
ADXN
Addex Therapeutics
0.7365 of 5 stars
$8.52
flat
N/A+3.3%$9.03M$460K-25.0630News Coverage
Analyst Forecast
Short Interest ↓
ENTO
Entero Therapeutics
N/A$5.40
-4.1%
N/A+127.4%$8.94MN/A0.009News Coverage
Analyst Forecast
Short Interest ↑
Gap Up
CELZ
Creative Medical Technology
1.4084 of 5 stars
$3.47
+1.8%
N/A-13.3%$8.80M$10K-1.095Positive News
Analyst Forecast
ALBT
Avalon GloboCare
0.9079 of 5 stars
$2.24
-2.2%
N/A-15.2%$8.78M$1.33M-0.115Gap Down
High Trading Volume
EVAX
Evaxion A/S
1.8952 of 5 stars
$7.84
+25.2%
$11.00
+40.3%
-49.9%$8.78M$3.34M-5.9460Analyst Forecast
Short Interest ↑
Gap Down

Related Companies and Tools


This page (NASDAQ:CYAN) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners